1-23-1 Toyama
Tokyo, 162-8640
Japan
National Institute of Infectious Diseases - Infectious Disease Surveillance Center
COVID-19, super-spreading events, heterogeneity, onward transmission, nightlife
SARS-CoV-2, COVID-19, Vaccine, Child, Adolescent
COVID-19, SARS-CoV-2, Vaccine, Child, Adolescent, Japan
COVID-19, Vaccine effectiveness against death, case fatality risk, medical burden
SARS-CoV-2, Omicron, vaccine effectiveness, mRNA vaccines, BNT162b2, mRNA-1273, systematic review and meta-analysis
SARS-CoV-2, COVID-19, surveillance, vaccine, hybrid immunity, reinfection, Omicron
Invasive pneumococcal disease, adult, Serotype, Pneumococcal vaccine, Indirect effect, Vaccination coverage